GlaxoSmithKline Pharmaceuticals, with its shares currently priced at Rs 3,292.30, remains a key stock to watch, particularly ...

GSK said on Friday the European Medicines Agency had accepted the drugmaker's application to expand the use of its ...

Pfizer's CEO discussed the extensive due diligence the company has conducted on the 3SBio PD-1xVEGF deal. | Pfizer's CEO ...

This Original Lifetime Movie, "Pretty Hurts," airs June 28, at 8 p.m.

What if you could actually see where a drug travels in the body down to the cellular level. Find out how mass spectrometry ...

GSK is putting the finishing touches on its case for antibody-drug conjugate Blenrep with a key progression-free survival ...

The global IPV vaccines market is estimated to be valued at USD 199.9 Mn in 2025 and expected to reach at USD 358.5 Mn by 2032 With a CAGR of 8.7% during the forecast period (2025-2032). Coherent ...

Dozens of states are suing to block 23andMe's sale of personal genetic data, citing concerns over customer consent and ...

The University of Waterloo’s School of Pharmacy announced Friday a partnership with multinational biopharma company ...

Volunteers from GSK helped to paint the garden furniture and fences at Elmhurst to improve the experience for residents at ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Based on these findings, mepolizumab is newly approved by the US Food and Drug Administration for the treatment of COPD according to manufacturer GlaxoSmithKline. “This decision is good news for ...